G9P8 rotavirus pseudovirus standard substance as well as preparation method and application thereof

By constructing a lentiviral vector containing VP4 and VP7 encoding genes, G9P8 rotavirus pseudovirus particles were prepared, and combined with the reverse transcription-digital PCR method, the standard substances in the prior art cannot meet the requirements of the rotavirus dual naming system. The problem has achieved the improvement of the accuracy and stability of rotavirus detection.

CN118909981APending Publication Date: 2024-11-08NATIONAL INSTITUTE OF METROLOGY CHINA
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410982917.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing rotavirus standard substances are mainly RNA form, which cannot simulate the complete structure of the virus, cannot provide quality control for the actual detection process, and cannot meet the needs of the current dual naming system of rotavirus, affecting the accuracy of detection.

Method used

Using the lentiviral vector construction method, including VP4 and VP7 encoding genes, G9P8 rotavirus pseudovirus particles were constructed, and quantitative analysis was performed by reverse transcription-digital PCR method to prepare pseudovirus particles containing VP7 and VP4 RNA. Specific storage solutions are diluted and stored to ensure the stability and accuracy of standard substances.

Benefits of technology

Provides pseudovirus standard substances containing VP7 and VP4 RNA, ensuring the accuracy and stability of detection, improving the scientificity and comparability of rotavirus detection, suitable for different digital PCR platforms, and suitable for G9P8 rotavirus The entire inspection process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909981A_ABST
    Figure CN118909981A_ABST
Patent Text Reader

Abstract

The invention discloses a G9P8 rotavirus pseudovirus standard substance as well as a preparation method and application thereof. The preparation method comprises the following steps: (1) preparing G9P8 rotavirus pseudovirus particles; (2) extracting and purifying the pseudovirus particles of the G9P8 rotavirus; (3) analyzing the uniformity and the stability of the pseudovirus of the G9P8 rotavirus; and (4) value determination and uncertainty analysis of the G9P8 rotavirus pseudovirus standard substance. According to the preparation method disclosed by the invention, pseudovirus construction and a reverse transcription-digital PCR (Polymerase Chain Reaction) method are combined, pseudovirus particles containing complete sequences of VP7 and VP4 RNA (Ribonucleic Acid) are constructed, a pseudovirus standard substance with a determined quantity value is developed, and the standard substance can be stably stored for 6 months at the temperature of 80 DEG C below zero. The method disclosed by the invention can be used for absolutely quantifying the RNA of VP7 and VP4 in the rotavirus G9P8 pseudovirus nucleic acid standard substance, so that the accuracy of the mass value of the standard substance is ensured.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of rotavirus pseudovirus standard substances, and in particular to a G9P8 rotavirus pseudovirus standard substance, a preparation method and an application thereof. Background Art

[0002] Rotavirus belongs to the genus Ratavivus of the family Reoviridae and was first discovered by Australian scientist Ruth Bishop et al. in 1973 from the duodenal epithelial cells of diarrhea patients.

[0003] The diameter of the rotavirus virion is 60 to 80 nm, spherical, with a core of phased double-stranded RNA, covered with two layers of capsid, and no envelope. Under electron microscopy, the inner capsid of the virus is composed of 22 to 24 radial subunits attached to the virus core, extending upward and merging with the capsid to form a wheel shape, hence the name rotavirus. The rotavirus genome consists of 11 discontinuous double-stranded RNA gene segments, each of which encodes a protein (VP1 to VP4, VP6, VP7, NSP1 to NSP5). Based on the difference in VP6 antigenicity, rotavirus can be divided into groups A to G, and the main group that infects humans is group A. Rotavirus has a high infection rate in the human population, especially in infants and young children, and is one of the main pathogens causing acute gastroenteritis. In addition, based on the differences in VP7 and VP4, rotavirus can be divided into multiple serotypes. For example, the group A rotavirus currently prevalent in my country is type G9P[8].

[0004] Quantitative detection of rotavirus is an important means in the diagnosis and treatment of acute gastroenteritis. In the early stage, researchers have developed immunoassay methods for rotavirus (ELISA, etc.). In recent years, quantitative measurement methods based on PCR technology have developed rapidly and are used for rotavirus nucleic acid detection. The quantitative results of fluorescent quantitative PCR (qPCR) method are widely used. However, qPCR relies on standard curves for quantitative analysis, and the accuracy of the results is affected by the standard curve.

[0005] CN108085411A discloses a group A rotavirus nucleic acid detection standard material and its preparation method and application, which is prepared by the following method: 1) screening group A rotavirus positive samples, extracting viral RNA, and amplifying DNA fragments after reverse transcription; 2) connecting the DNA fragments described in step 1) with plasmid vectors to construct recombinant plasmids; 3) transforming the recombinant plasmids obtained in step 2) into competent cells, proliferating, and extracting recombinant plasmids; 4) using restriction endonucleases to perform single enzyme digestion on the recombinant plasmids extracted in step 3) to obtain linearized recombinant plasmids; 5) using the linearized recombinant plasmids as templates, in vitro transcription synthesis to obtain group A rotavirus nucleic acid detection standard material candidates, diluting, and then using RT-dPCR method, after uniformity and stability testing, performing fixed value and uncertainty evaluation, that is. However, the preparation method develops standard materials in the form of RNA, does not contain viral capsid structure, and cannot provide a reference for quality control of the nucleic acid extraction process. At the same time, RNA-based standard materials have significant limitations and are not suitable for the detection of actual virus samples. RNA is also easily degraded and has high requirements for transportation and operation.

[0006] CN112359022A discloses a novel coronavirus nucleic acid pseudovirus standard material for detection and a preparation method thereof, wherein the standard material includes pseudovirus particles in which protein encapsulates RNA; the preparation method of the pseudovirus standard material comprises the following steps: 1) synthesizing a target nucleic acid sequence; 2) connecting the cloned gene to a lentiviral expression vector by homologous recombination to obtain a recombinant expression plasmid; 3) transforming the obtained recombinant expression plasmid, pseudovirus packaging plasmid and pseudovirus envelope plasmid into Escherichia coli respectively, amplifying them, and extracting the corresponding plasmids respectively; 4) co-transfecting the recombinant expression plasmid, pseudovirus packaging plasmid and envelope plasmid obtained in the previous step into cells to package pseudovirus particles, thereby obtaining pseudovirus particles secreted in the supernatant and packaging the target RNA; 5) collecting the cell culture supernatant of the previous step, and obtaining a crude product of pseudovirus particles after centrifugation and filtration. However, this preparation method is also not suitable for preparing G9P8 rotavirus pseudovirus standard material for the following reasons: 1) Rotavirus adopts a dual naming system, that is, the difference between the two proteins VP7 and VP4 is clearly used to jointly determine the virus typing. The new coronavirus has not yet clearly used the difference in protein or coding gene as the basis for typing; 2) The patent includes fragments of the O gene, N gene and E gene, which obviously limits the scope of use of this standard material and there is a certain gap with the actual detection process; 3) The content ratio of the three gene RNAs is not explained.

[0007] In summary, there are two main limitations in the current research of rotavirus reference materials:

[0008] (1) Most standard materials are in RNA form, which cannot simulate the complete structure of the virus and cannot provide quality control for the nucleic acid extraction process in the actual detection process; (2) When the differences between the two structural proteins VP7 and VP4 are used as the dual naming system, it is usually necessary to detect and analyze the RNA of VP7 and VP4 at the same time. The existing standard materials basically use VP7 RNA as the target sequence, which cannot fully contain the VP7 and VP4 RNA sequences, cannot meet the needs of the current dual naming system of rotavirus, and cannot provide accurate values, which greatly affects the accuracy of actual detection. Summary of the invention

[0009] The purpose of the present invention is to provide a G9P8 rotavirus pseudovirus standard substance and a preparation method and application thereof.

[0010] To achieve the above purpose, the technical solution adopted by the present invention is as follows:

[0011] A method for preparing a G9P8 rotavirus pseudovirus standard substance comprises the following steps:

[0012] (1) Preparation of G9P8 rotavirus pseudovirion particles

[0013] 1) Lentiviral vector construction

[0014] The lentiviral vector contains the coding genes of VP4 and VP7, which are GenBank: MH182439.1 and GenBank: MH182443.1 respectively; wherein the VP4 gene sequence is located at the N-terminus of the VP7 gene sequence;

[0015] 2) 293A cells were seeded into 6-well plates and placed in a 37°C, 5% CO2 incubator until the cells covered 80%-90% of the culture dish;

[0016] 3) Solution A: Dissolve the constructed lentiviral vector containing the coding genes of VP4 and VP7 in 500 μL DMEM liquid culture medium and shake to mix;

[0017] 4) Solution B: Dissolve the PEI solution in 500 μL DMEM liquid culture medium and shake to mix;

[0018] 5) Let stand for 5 minutes, mix liquid A and liquid B evenly to obtain liquid C;

[0019] 6) Place solution C in a 37°C incubator away from light for 15 min;

[0020] 7) Add solution C evenly into the cell culture medium and shake gently;

[0021] 8) Replace the cell medium with the above culture medium, incubate at 37°C in a CO2 incubator for 4 hours, and then replace the medium;

[0022] 9) After continuing to culture for 48 hours, the cells were collected;

[0023] (2) Extraction and purification of G9P8 rotavirus pseudovirions;

[0024] (3) Dilution and storage of pseudovirus standard substances;

[0025] (4) Analysis of the homogeneity and stability of G9P8 rotavirus pseudovirus;

[0026] (5) Determination and uncertainty analysis of G9P8 rotavirus pseudovirus reference material.

[0027] Furthermore, the step (2) is specifically as follows:

[0028] 1) Promote cell disruption and pseudovirus release by ultrasonic treatment;

[0029] 2) Separate using a high-speed centrifuge, remove the supernatant after centrifugation, collect the sediment and dissolve it again;

[0030] 3) The dissolved sample is added to an ultracentrifuge tube, and pseudovirus particles are separated by cesium chloride density gradient centrifugation.

[0031] Furthermore, the step (3) is specifically as follows:

[0032] 1) Mix 600 μL of G9P8 rotavirus pseudovirus solution with 23400 μL of virus preservation solution, and place the mixed solution in a 4°C refrigerator and shake it thoroughly to ensure uniform mixing; wherein the virus preservation solution is specifically PBS solution with 1% BSA, 5% trehalose, 20 U / ml RNase inhibitor and 5 ng / ul yeast RNA added thereto.

[0033] 2) Dispense the mixed pseudovirus solution into 0.5 mL cryovials, 120 μL per tube;

[0034] 3) Store the aliquoted pseudovirus standard substance in a -80°C refrigerator.

[0035] Furthermore, the step (5) is specifically to establish a RT-dPCR quantitative method based on digital PCR technology; design specific primers and probes for the G gene and the P gene, respectively, and the sequences are shown in SEQ ID NO: 1-6;

[0036]

[0037]

[0038] Primer probes for the G gene were selected, with an annealing temperature of 54°C, upstream and downstream primer concentrations of 500 nM, and probe concentrations of 300 nM. The PCR amplification system was as follows: RT-dPCR Mastermix 11 μL, Enzyme Mix 2 μL, upstream and downstream primers 1.1 μL each, probe 0.66 μL, RNA template 2.2 μL, and nuclease-free water was added to make up the final volume to 22 μL. 22 μL of the reaction mixture was dispensed into the corresponding eight-row sample wells for droplet generation, droplet generation was performed, and PCR reaction was performed. The PCR amplification conditions were as follows:

[0039]

[0040] After the PCR reaction amplification is completed, the results are read; the results with an acceptable average number of droplets greater than 20,000 produced in the reaction are selected for analysis; 10 units are randomly selected for RNA extraction and determination, and the average value of the determination results of the 10 units is used as the amount of the standard substance.

[0041] The G9P8 rotavirus pseudovirus standard substance prepared by the invention can be used for preparing a G9P8 rotavirus detection kit.

[0042] Compared with the prior art, the outstanding effects of the present invention are:

[0043] (1) The preparation method of the G9P8 rotavirus pseudovirus standard substance of the present invention combines pseudovirus construction with the reverse transcription-digital PCR method to construct pseudovirus particles containing VP7 and VP4 RNA, and adopts a targeted preservation solution to develop a pseudovirus standard substance with a certain value. The pseudovirus standard substance can be stably stored at -80°C for 6 months. Compared with RNA, the pseudovirus standard substance is more stable.

[0044] (2) The method of the present invention can perform absolute quantification of the RNA of VP7 and VP4 in the rotavirus G9P8 pseudovirus nucleic acid standard material, thereby ensuring the accuracy of the mass value of the standard material.

[0045] (3) The G9P8 rotavirus pseudovirus standard substance of the present invention can improve the accuracy of G9P8 detection on different platforms.

[0046] (4) The standard substance and quantitative method prepared by the present invention can be applied to the detection process of rotavirus G9P8, thereby improving the scientificity of the diagnosis and treatment of acute enteritis and other related diseases.

[0047] (5) The G9P8 rotavirus pseudovirus standard material prepared by the present invention includes the complete sequences of VP7 and VP4 RNA, which can eliminate the influence of RNA fragments on the limitations of the detection method. The complete sequence is closer to the actual virus sample and can be used as a reference for the entire process of G9P8 rotavirus detection and typing.

[0048] (6) The pseudovirus standard substance prepared by the present invention is used for performance comparison of different digital PCR platforms, so that each platform has a unified measurement standard and ensures the comparability of the measurement results.

[0049] The G9P8 rotavirus pseudovirus standard substance and its preparation method and application described in the present invention are further described below in conjunction with the accompanying drawings and specific examples. BRIEF DESCRIPTION OF THE DRAWINGS

[0050] Figure 1 This is a photo of the G9P8 rotavirus pseudovirus standard substance prepared by the present invention;

[0051] Figure 2-Figure 3 Optimize results for temperature;

[0052] Figure 4 The results of primer and probe concentration optimization for the G gene;

[0053] Figure 5 The results of primer and probe concentration optimization for the P gene;

[0054] Figure 6 To validate the results of droplet digital PCR method specificity;

[0055] Figure 7 is the linear range result;

[0056] Figure 8 The short-term stability results of the G9P8 rotavirus pseudovirus standard substance prepared by the present invention;

[0057] Fig. 9 The performance comparison results of the G9P8 rotavirus pseudovirus standard substance prepared by the present invention on different digital PCR platforms. DETAILED DESCRIPTION

[0058] 1. Preparation of reference materials

[0059] 1. Preparation of G9P8 rotavirus pseudovirion particles

[0060] (1) Lentiviral vector construction

[0061] The lentiviral vector contains the coding genes of VP4 and VP7, which are GenBank: MH182439.1 and GenBank: MH182443.1 respectively; wherein the VP4 gene sequence is located at the N-terminus of the VP7 gene sequence; VP7 determines the G classification, and VP4 determines the P classification.

[0062] 1) Synthesize the gene sequences encoding VP4 and VP7;

[0063] 2) inserting the VP4 and VP7 coding gene sequences into a lentiviral vector;

[0064] 3) Transform the complete lentiviral vector into competent E. coli cells;

[0065] 4) Overnight culture of E. coli;

[0066] 5) Extract the lentiviral vector using a plasmid extraction kit;

[0067] 6) Use sequencing methods to determine the accuracy of the VP4 and VP7 coding gene sequences.

[0068] (2) 293A cells were seeded into 6-well plates and cultured in a 37°C, 5% CO2 incubator until the cells covered 80%-90% of the culture dish;

[0069] (3) Solution A: Dissolve the constructed plasmid containing the target gene in 500 μL DMEM liquid culture medium and shake to mix;

[0070] (4) Solution B: Dissolve the polyethyleneimine solution in 500 μL DMEM liquid culture medium and shake to mix;

[0071] (5) Let stand for 5 min, mix liquid A and liquid B evenly to obtain liquid C;

[0072] (6) Place solution C in a 37°C incubator away from light for 15 min;

[0073] (7) Add Solution C evenly into the cell culture medium and shake gently;

[0074] (8) Replace the cell medium with the above culture medium, incubate the cells at 37°C in a CO2 incubator for 4 h, and then replace the medium;

[0075] (9) After 48 h of continuous culture, cells were collected;

[0076] 2. Extraction and Purification of Pseudoviral Particles

[0077] (1) Promoting cell disruption and pseudovirus release through ultrasonic treatment;

[0078] (2) Separate using a high-speed centrifuge, centrifuge at high speed for 3 hours, remove the supernatant after centrifugation, collect the sediment and dissolve it again;

[0079] (3) The dissolved pseudovirus suspension is added to an ultracentrifuge tube, and pseudovirus particles are separated by cesium chloride density gradient centrifugation.

[0080] 3. Dilution and storage of pseudovirus standard substances

[0081] To ensure that the concentration of the pseudovirus standard substance is suitable for measurement, it is diluted and stored as follows. The packaging process of the standard substance is carried out in a biological safety cabinet. Figure 1 shown.

[0082] 1) Take 600 μL of G9P8 rotavirus pseudovirus solution and mix it with 23400 μL of virus preservation solution, and place the mixed solution in a 4°C refrigerator and shake it thoroughly to ensure uniform mixing. Among them, the virus preservation solution for diluting the standard substance is specifically PBS solution with 1% BSA, 5% trehalose, 20U / ml RNase inhibitor and 5ng / ul yeast RNA added.

[0083] 2) The evenly mixed pseudovirus solution was dispensed into 0.5 mL cryovials, 120 μL per tube, for a total of 200 tubes.

[0084] 3) Place the subpackaged pseudovirus standard substances in plastic boxes, 100 tubes per box, and store them in a -80°C refrigerator.

[0085] 2. Value determination method

[0086] 1. Primer probe sequence

[0087] This experiment was based on a droplet digital PCR platform (Sinafo, DQ24), and an RT-dPCR quantitative method was established and optimized. Specific primers and probes were designed for the G gene and the P gene, respectively, and the specific sequences are shown in SEQ ID NO: 1-6.

[0088] Table 1 RT-dPCR primer and probe sequences

[0089]

[0090]

[0091] After comparing the amplification effects of the two groups of probes, including the annealing temperature ( Figure 2-Figure 3 ), optimization of probe concentration ( Figure 4-Figure 5 ), finally selected the primer probe for the G gene, determined the annealing temperature of 54°C, the concentration of upstream and downstream primers of 500nM, the probe concentration of 300nM, and the PCR amplification system (22μL): RT-dPCR Mastermix 11μL, Enzyme Mix 2μL, 1.1μL of upstream and downstream primers, 0.66μL of probe, 2.2μL of RNA template, and added nuclease-free water to make up the final volume to 22μL. The 22μL reaction mixture was dispensed into the corresponding eight-row sample wells for droplet generation, and a can of droplet generation oil was added to the oil tank of the Sinafo platform to generate droplets and perform PCR reactions. The PCR amplification conditions are shown in Table 2.

[0092] Table 2 PCR amplification conditions

[0093]

[0094] After the PCR reaction is completed, the results are read. The results with an acceptable average number of droplets greater than 20,000 are selected for analysis to ensure the accuracy of quantitative analysis.

[0095] 2. Specificity of digital PCR method

[0096] To verify the specificity of the established method, the above rotavirus G9P8 primer probe was used to amplify RNA extracted from rotavirus G1P8 / G3P8 as template. The amplification results were as follows: Figure 6 , from left to right are the amplification results of G9 / G1 / G3. When the rotavirus G9P8 primer probe was used, only the PCR reaction of the rotavirus G9P8 RNA template was positive, while the other reactions were negative, indicating that the established PCR primer probe for rotavirus G9P8 has good specificity for its template.

[0097] 3. Linear range of digital PCR method

[0098] When using digital PCR to detect nucleic acid concentration, the nucleic acid concentration needs to be within the detection range of digital PCR. To verify the linear range of the established method, the RNA samples of pseudoviruses with known concentrations were graded diluted using the gravimetric method and detected using the established RT-dPCR method. The lowest reading was 2 copies / μL and the highest reading was 3554 copies / μL. The linear correlation between the digital PCR results and the gravimetric results was compared, as shown in Figure 2. Figure 7 The results showed that the digital PCR method established in the experiment had a good linear relationship within at least 3 orders of magnitude, and the corresponding R 2 is 0.9997.

[0099] 4. Limit of quantification and detection of RT-dPCR method

[0100] According to the requirements of EP17-A, the limit of blank (LoB) and limit of detection (LoD) of the RT-dPCR method were established from replicate measurements of 60 blank and low-concentration samples by RT-dPCR, and the results are shown in Table 3.

[0101] Table 3 Test results of blank samples and low concentration samples

[0102]

[0103] According to EP17-A: If the distribution of blank values ​​and low-level sample measurement values ​​is Gaussian, LoB and LoD are calculated by formulas (1) and (2):

[0104] LoB = μB + 1.645 σB (1)

[0105] Note: μB and σB are the mean and standard deviation of blank measurements, respectively.

[0106] LoD = μB + 1.645 σB + 1.645 σs (2)

[0107] Note: σs is the standard deviation of the low sample measurement population.

[0108] The LoD of the RT-dPCR method was 5 copies / μL.

[0109] The LoQ of the RT-dPCR method was determined from four independent dilutions at each level, which were analyzed ten times by RT-dPCR (Table 4). According to EP17-A: The standard deviation (SD) of 40 results was used to estimate the total error, using Bias + 2 × SDs = total error. The difference between the RT-dPCR results and the nominal concentration was normally distributed. Using the Bland and Altman method, the total error can be calculated by formula (3).

[0110] Total error = x ± (t × s) (3)

[0111] Note: x is the mean difference; t is the value in the T table corresponding to the number of degrees of freedom (the total number of samples minus 1); s is the standard deviation of the difference.

[0112] Finally, the total error of the RT-dPCR method ranged from -2.56 copies / μL to 4.03 copies / μL.

[0113] Table 4 Quantitative results of four levels of dilution

[0114]

[0115] For Rotavirus G9P8 RT-dPCR data, 2×SD=2×1.41=2.82 copies / μL. The total error is within the total error target range (2.82 copies / μL<4.03 copies / μL). According to EP17-A, if this estimate is less than the total error target definition value, then: LoQ=LoD=5 copies / μL.

[0116] 3. Uniformity test

[0117] 1. Uniformity test method

[0118] The above-established value determination method RT-dPCR method was used for uniformity test. Since 200 tubes were prepared for each candidate standard substance, 11 packaging units were randomly selected for each standard substance in accordance with the technical requirements for standard substance uniformity evaluation in the national metrology technical specification JJF 1343-2022 "Value determination and uniformity stability evaluation of standard substances". The extracted samples were measured under the same experimental conditions, so that the differences between the samples were completely reflected by the heterogeneity of the samples. RNA was extracted from each tube of standard substance according to the extraction scheme in the kit DNeasy Blood&Tissue Kit 250 to obtain an amplification template, which was amplified according to the established digital PCR method. Each tube of sample was measured three times, and the data results are shown in Table 4. The obtained data were subjected to an F test. Assuming that there are a units of standard substances, unit i was measured ni times, and the mean square M between groups was calculated according to formulas (4) and (5): between and the degrees of freedom between groups and the mean square within groups M within and the degrees of freedom within the group, the standard deviation S between units is calculated according to formula (8) bb , and as the uncertainty component U introduced by uniformity bb .

[0119]

[0120] in:

[0121]

[0122] in:

[0123]

[0124] 2. Uniformity test results

[0125] The Shapiro-Wilk method was first used to test the normality of the data results of digital PCR. After the test, the uniformity data of all standard substances satisfied the normal distribution. After the F test, the results showed that the F <F 0.05 (v1, v2), that is, there is no significant difference in the internal homogeneity of the standard substance solution. If the calculated inter-group standard deviation S bb Greater than the standard deviation of repeatability within the group S r , the uncertainty of uniformity is calculated using formula (10); if the standard deviation between groups S bb Smaller than the standard deviation of repeatability within the group S r , then use formula (11) to calculate.

[0126]

[0127] From the uniformity data in Table 5, we can see that the uniformity test result of the developed standard material is F <F a , indicating that these standard substances have good uniformity.

[0128] Table 5. Test results of homogeneity of G9P8 rotavirus pseudovirus standard material

[0129]

[0130] 4. Stability inspection

[0131] 1. Short-term stability study

[0132] The short-term stability test is to ensure the stability of the standard substance under transportation conditions. Therefore, the short-term stability is investigated at three temperatures: -20°C, 4°C and room temperature. Three units are randomly selected at four time points: day 0, day 3, day 7 and day 14, and the copy number concentration is measured. The standard substance stored at -80°C is used as the reference temperature. Figure 8 The T test results showed that compared with the -80℃ condition, the target gene copy number of the standard material did not change significantly within 14 days under the -20℃ and 4℃ storage conditions. Therefore, the amount of the standard material can be kept stable as long as the transportation time does not exceed 14 days by adding dry ice during transportation or controlling the temperature not to exceed 4℃.

[0133] 2. Long-term stability study

[0134] Long-term stability was investigated under -80℃ storage conditions, and the sampling time points were based on the principle of dense first and sparse later. Three units were randomly selected for each storage condition each time to investigate their long-term storage stability under -80℃ conditions. Long-term stability was investigated at 0 months, 1 month, 3 months, and 6 months respectively.

[0135] The results of the long-term stability analysis of the standard substances are shown in Table 6. The analysis of the long-term stability data is carried out according to JJF-1343-2022 "Value determination and uniformity stability evaluation of standard substances", that is, the time (x i ) as the horizontal axis, and the gene copy number concentration (y i ) as the ordinate, perform linear fitting, and record the intercept (b0) and slope (b1) of the straight line respectively. Calculate the standard deviation and uncertainty (s(b1)) of the slope according to formula (12) and formula (13). The degree of freedom is n-2, n is the number of sampling measurements, and according to the t critical value table, check the t in the Student distribution with P = 0.95 (95% confidence level). 0.95,n-2 If b1 <s(b1)*t 0.95,n-2 , then the standard substance is stable under this condition.

[0136] The long-term stability results show that the value of the standard substance is stable within 6 months when stored at -80℃. <s(b1)*t0. 95,n-2 Therefore, no significant changes were found and the standard substance was stable under this storage condition.

[0137]

[0138] Table 6 Long-term stability of standard substances

[0139]

[0140]

[0141] 5. Reference Material Value Determination

[0142] 1. Fixed value results

[0143] 10 units were measured respectively, and each unit was measured 3 times. The G9P8 rotavirus pseudovirus standard material was determined by the NIM-verified droplet digital PCR method. The gene copy number concentration of each standard material was calculated as the value of the standard material, as shown in Table 7 below. First, the raw data was subjected to Grubbs's test to eliminate outliers. No suspicious values ​​were found after the test.

[0144] Table 7 Original data of Sinafu platform setting

[0145]

[0146] 2. Uncertainty of the determination method

[0147] Since the average value of the copy number concentration of ten tubes of standard substances was used as the quantity value of the standard substance, the uncertainty of the average value was calculated according to formula (14) and used as the uncertainty introduced by the determination method, see Table 8.

[0148]

[0149] Table 8 Uncertainty components of the determination method

[0150] Characteristic quantity G9P8 rotavirus pseudovirus standard material Standard value (copies / μL) 3515 <![CDATA[u 定值 (%)]]> 3.67

[0151] 3. Uniformity (u bb ) introduces uncertainty

[0152] From the development process of this standard material, it can be seen that the sample is uniform after the uniformity test. The uncertainty introduced by the uniformity is shown in Table 5.

[0153] 4. Stability (u s ) introduces uncertainty

[0154] Long-term stability has a certain linear relationship with time. t is time (month), s(b1) is the standard deviation of the straight line, and s(b1) is calculated according to formula (13). The stability is tentatively set at 6 months. The results are shown in Table 9.

[0155] Table 9 Uncertainty analysis of long-term stability

[0156] Characteristic quantity G9P8 rotavirus pseudovirus standard material s(b1) 51.394 t(month) 6 <![CDATA[u S (copies / μL)]]> 308.364 <![CDATA[u S rel (%)]]> 8.77

[0157] 5. Combined standard uncertainty (u c )assessment

[0158] The relative uncertainties of the above three parts are combined according to formula (15) to obtain the combined standard uncertainty of the standard value of the reference material (u c ), see Table 10.

[0159]

[0160] Table 10 Uncertainty components of standard materials

[0161] Characteristic quantity G9P8 rotavirus pseudovirus standard material <![CDATA[u 定值 (%)]]> 3.67 <![CDATA[u bb rel (%)]]> 0.24 <![CDATA[u S rel (%)]]> 8.77 <![CDATA[u c rel (%)]]> 9.51 <![CDATA[U rel (k=2)(%)]]> 19.02

[0162] 6. Evaluation of expanded uncertainty (U)

[0163] Taking the inclusion factor k equal to 2, at a 95% confidence level, according to the formula U = k × u c The expanded uncertainty (U) of the reference material can be obtained, as shown in Table 11. After analysis, the relative expanded uncertainty corresponding to the characteristic value of the gene copy number concentration of the G9P8 rotavirus pseudovirus reference material is 19.02%.

[0164] Table 11 Standard substance mass values

[0165]

[0166] 6. The influence of the connection mode between VP7 coding gene and VP4 coding gene

[0167] During the experiment, it was also found that when the VP4 gene sequence was located at the N-terminus of the VP7 gene sequence, the concentration ratio of the two RNAs was close to 1:1 (therefore, the preparation method of the present invention adopts this method), and when the VP7 coding gene was located at the C-terminus of the VP4 coding gene, the concentration ratio of the two RNAs was about 1.2, and the degree of distinction between positive droplets and negative droplets was poor.

[0168]

[0169] VII. Performance comparison of G9P8 rotavirus pseudovirus reference material on different digital PCR platforms

[0170] In previous digital PCR platform research, there was a lack of comparison of the detection performance of different digital PCR platforms. This problem was mainly caused by the following two reasons: (1) Researchers lacked an understanding of the differences between platforms and unilaterally believed that various platforms had absolute and uniform accuracy; (2) There was a lack of unified standards for comparing different platforms, which made it difficult to ensure the comparability of measurement results.

[0171] In view of the above problems, the present invention uses the prepared rotavirus pseudovirus standard material to compare the performance of different digital PCR platforms (A, B, C, D). Fig. 9 The results showed that the measurement results of the A, B, and D platforms were not significantly different when the rotavirus pseudovirus standard substance was analyzed using the established RT-dPCR method system, and the measurement results of the C platform were significantly lower than those of the other three platforms. This indicates that there may be a systematic error in the C platform, which will affect the determination of the rotavirus content and lead to misjudgment of disease treatment.

[0172] In summary, the standard substances with quantitative values ​​prepared by the present invention can be used as measurement "tools" to provide references for quality control of different detection methods, platforms and laboratories. The promotion and application of standard substances can improve the accuracy and scientificity of rotavirus detection and help the diagnosis and treatment of related diseases.

[0173] The embodiments described above are merely descriptions of preferred implementation modes of the present invention and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. A method for preparing a G9P8 rotavirus pseudovirus standard substance, characterized in that: The following steps are involved: (1) Preparation of G9P8 rotavirus pseudovirion particles 1) Lentiviral vector construction The lentiviral vector contains the coding genes of VP4 and VP7, which are GenBank: MH182439.1 and GenBank: MH182443.1 respectively; wherein the VP4 gene sequence is located at the N-terminus of the VP7 gene sequence; 2) 293A cells were seeded into 6-well plates and placed in a 37°C, 5% CO2 incubator until the cells covered 80%-90% of the culture dish; 3) Solution A: Dissolve the constructed lentiviral vector containing the coding genes of VP4 and VP7 in 500 μL DMEM liquid culture medium and shake to mix; 4) Solution B: Dissolve the PEI solution in 500 μL DMEM liquid culture medium and shake to mix; 5) Let stand for 5 minutes, mix liquid A and liquid B evenly to obtain liquid C; 6) Place solution C in a 37°C incubator away from light for 15 min; 7) Add solution C evenly into the cell culture medium and shake gently; 8) Replace the cell medium with the above culture medium, incubate at 37°C in a CO2 incubator for 4 hours, and then replace the medium; 9) After continuing to culture for 48 hours, the cells were collected; (2) Extraction and purification of G9P8 rotavirus pseudovirions; (3) Dilution and storage of pseudovirus standard substances; (4) Analysis of the homogeneity and stability of G9P8 rotavirus pseudovirus; (5) Determination and uncertainty analysis of G9P8 rotavirus pseudovirus reference material.

2. The method for preparing the G9P8 rotavirus pseudovirus standard substance according to claim 1, characterized in that: The step (2) is specifically: 1) Promote cell disruption and pseudovirus release by ultrasonic treatment; 2) Separate using a high-speed centrifuge, remove the supernatant after centrifugation, collect the sediment and dissolve it again; 3) The dissolved sample is added to an ultracentrifuge tube, and pseudovirus particles are separated by cesium chloride density gradient centrifugation.

3. The method for preparing the G9P8 rotavirus pseudovirus standard substance according to claim 2, characterized in that: The step (3) is specifically: 1) Mix the G9P8 rotavirus pseudovirus solution with an appropriate amount of virus preservation solution, and shake the mixed solution thoroughly in a 4°C refrigerator to ensure uniform mixing; 2) Dispense the mixed pseudovirus solution into 0.5 mL cryovials, 120 μL per tube; 3) Store the aliquoted pseudovirus standard substance in a -80°C refrigerator.

4. The method for preparing the G9P8 rotavirus pseudovirus standard substance according to claim 3, characterized in that: The virus preservation solution is specifically a PBS solution with 1% BSA, 5% trehalose, 20 U / ml RNase inhibitor and 5 ng / ul yeast RNA added thereto.

5. The method for preparing the G9P8 rotavirus pseudovirus standard substance according to claim 4, characterized in that: The step (5) specifically includes establishing an RT-dPCR quantitative method based on digital PCR technology; designing specific primers and probes for the coding genes of VP4 and VP7, respectively, and the sequences are shown in SEQ ID NO: 1-6; Primer probes for the G gene were selected, with an annealing temperature of 54°C, upstream and downstream primer concentrations of 500 nM, and probe concentrations of 300 nM. The PCR amplification system was as follows: RT-dPCR Mastermix 11 μL, Enzyme Mix 2 μL, upstream and downstream primers 1.1 μL each, probe 0.66 μL, RNA template 2.2 μL, and nuclease-free water was added to make up the final volume to 22 μL. 22 μL of the reaction mixture was dispensed into the corresponding eight-row sample wells for droplet generation, droplet generation was performed, and PCR reaction was performed. The PCR amplification conditions were as follows: After the PCR reaction amplification is completed, the results are read; the results with an acceptable average number of droplets greater than 20,000 produced in the reaction are selected for analysis; 10 units are randomly selected for RNA extraction and determination, and the average value of the determination results of the 10 units is used as the amount of the standard substance.

6. The method for preparing the G9P8 rotavirus pseudovirus standard substance according to claim 5, characterized in that: The uncertainty includes the uncertainty of the determination method, the uncertainty introduced by uniformity, the uncertainty introduced by stability, the combined standard uncertainty, and the expanded uncertainty.

7. The G9P8 rotavirus pseudovirus standard substance prepared by the preparation method according to any one of claims 1 to 6.

8. Use of the G9P8 rotavirus pseudovirus standard substance according to claim 7 in the evaluation of a G9P8 rotavirus detection kit and in providing quality control for a measurement platform and a measurement method.

Citation Information

Cited By

  • Method for evaluating copy number of specific nucleic acid in quantitative pseudovirus antigen standard

    CN119859673A